Participants who must be prescribed macitentan/tadalafil fixed dose combination (M/T FDC) based on the locally approved label and the physician's medical judgment
Participants who must sign a participation agreement/ICF allowing source data verification in accordance with local requirements
You may not be if
Participants who have any contraindications to M/T FDC, based on the locally approved label
Participants who currently are participating in other interventional clinical trials
Clareo Health | A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea
